Cargando…
Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer
BACKGROUND: This study investigated the clinical relevance and prognostic impact of the overall expression of programmed cell death protein ligand-1 (PD-L1) and programmed cell death protein ligand-2 (PD-L2), in patients with Epstein–Barr virus-associated gastric cancer (EBVaGC). METHODS: After revi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729479/ https://www.ncbi.nlm.nih.gov/pubmed/29073638 http://dx.doi.org/10.1038/bjc.2017.369 |
_version_ | 1783286205720297472 |
---|---|
author | Seo, An Na Kang, Byung Woog Kwon, Oh Kyoung Park, Ki Bum Lee, Seung Soo Chung, Ho Young Yu, Wansik Bae, Han Ik Jeon, Seong Woo Kang, Hyojeung Kim, Jong Gwang |
author_facet | Seo, An Na Kang, Byung Woog Kwon, Oh Kyoung Park, Ki Bum Lee, Seung Soo Chung, Ho Young Yu, Wansik Bae, Han Ik Jeon, Seong Woo Kang, Hyojeung Kim, Jong Gwang |
author_sort | Seo, An Na |
collection | PubMed |
description | BACKGROUND: This study investigated the clinical relevance and prognostic impact of the overall expression of programmed cell death protein ligand-1 (PD-L1) and programmed cell death protein ligand-2 (PD-L2), in patients with Epstein–Barr virus-associated gastric cancer (EBVaGC). METHODS: After reviewing 1318 consecutive cases of surgically resected or endoscopic submucosal dissected gastric cancers, the expression status of PD-L1 and PD-L2 in 120 patients with EBVaGC identified by EBV-encoded RNA in situ hybridisation was retrospectively analysed using immunohistochemistry (IHC). For each IHC marker, positivity was separately in intraepithelial tumour cells (iTu-) and immune cells in the tumour stroma area (str-). RESULTS: Among 116 eligible patients, 57 (49.1%) and 66 patients (56.9%) were determined as iTu-PD-L1-positive and str-PD-L1-positive, respectively, whereas 23 (21.6%) and 45 patients (38.8%) were determined as iTu-PD-L2 positive and str-PD-L2 positive, respectively. Intraepithelial tumour cell PD-L1 positivity was found to be significantly associated with lymph node (LN) metastasis (P=0.012) and a poor disease-free survival (DFS) (P=0.032), yet not overall survival (P=0.482). In a multivariate analysis, iTu-PD-L1 positivity was independently associated with a poor DFS (P=0.006, hazard ratio=12.085). In contrast, str-PD-L2-positivity was related to a lower T category (P=0.003), absence of LN metastasis (P=0.032) and perineural invasion (P=0.028). Intraepithelial tumour cell and str-PD-L2 positivity showed a trend towards an improved DFS, although not significant (P=0.060 and P=0.073, respectively). CONCLUSIONS: Intraepithelial tumour cells PD-L1 expression can be used to predict a poor outcome in patients with EBVaGC and can represent a rational approach for PD-1/PD-L pathway-targeted immunotherapy. |
format | Online Article Text |
id | pubmed-5729479 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57294792018-12-05 Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer Seo, An Na Kang, Byung Woog Kwon, Oh Kyoung Park, Ki Bum Lee, Seung Soo Chung, Ho Young Yu, Wansik Bae, Han Ik Jeon, Seong Woo Kang, Hyojeung Kim, Jong Gwang Br J Cancer Clinical Study BACKGROUND: This study investigated the clinical relevance and prognostic impact of the overall expression of programmed cell death protein ligand-1 (PD-L1) and programmed cell death protein ligand-2 (PD-L2), in patients with Epstein–Barr virus-associated gastric cancer (EBVaGC). METHODS: After reviewing 1318 consecutive cases of surgically resected or endoscopic submucosal dissected gastric cancers, the expression status of PD-L1 and PD-L2 in 120 patients with EBVaGC identified by EBV-encoded RNA in situ hybridisation was retrospectively analysed using immunohistochemistry (IHC). For each IHC marker, positivity was separately in intraepithelial tumour cells (iTu-) and immune cells in the tumour stroma area (str-). RESULTS: Among 116 eligible patients, 57 (49.1%) and 66 patients (56.9%) were determined as iTu-PD-L1-positive and str-PD-L1-positive, respectively, whereas 23 (21.6%) and 45 patients (38.8%) were determined as iTu-PD-L2 positive and str-PD-L2 positive, respectively. Intraepithelial tumour cell PD-L1 positivity was found to be significantly associated with lymph node (LN) metastasis (P=0.012) and a poor disease-free survival (DFS) (P=0.032), yet not overall survival (P=0.482). In a multivariate analysis, iTu-PD-L1 positivity was independently associated with a poor DFS (P=0.006, hazard ratio=12.085). In contrast, str-PD-L2-positivity was related to a lower T category (P=0.003), absence of LN metastasis (P=0.032) and perineural invasion (P=0.028). Intraepithelial tumour cell and str-PD-L2 positivity showed a trend towards an improved DFS, although not significant (P=0.060 and P=0.073, respectively). CONCLUSIONS: Intraepithelial tumour cells PD-L1 expression can be used to predict a poor outcome in patients with EBVaGC and can represent a rational approach for PD-1/PD-L pathway-targeted immunotherapy. Nature Publishing Group 2017-12-05 2017-10-26 /pmc/articles/PMC5729479/ /pubmed/29073638 http://dx.doi.org/10.1038/bjc.2017.369 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Clinical Study Seo, An Na Kang, Byung Woog Kwon, Oh Kyoung Park, Ki Bum Lee, Seung Soo Chung, Ho Young Yu, Wansik Bae, Han Ik Jeon, Seong Woo Kang, Hyojeung Kim, Jong Gwang Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer |
title | Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer |
title_full | Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer |
title_fullStr | Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer |
title_full_unstemmed | Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer |
title_short | Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer |
title_sort | intratumoural pd-l1 expression is associated with worse survival of patients with epstein–barr virus-associated gastric cancer |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729479/ https://www.ncbi.nlm.nih.gov/pubmed/29073638 http://dx.doi.org/10.1038/bjc.2017.369 |
work_keys_str_mv | AT seoanna intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT kangbyungwoog intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT kwonohkyoung intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT parkkibum intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT leeseungsoo intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT chunghoyoung intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT yuwansik intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT baehanik intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT jeonseongwoo intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT kanghyojeung intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer AT kimjonggwang intratumouralpdl1expressionisassociatedwithworsesurvivalofpatientswithepsteinbarrvirusassociatedgastriccancer |